RPL22 and breast carcinoma: We further performed a ribosome immunoprecipitation assay using Flag antibody to detect ARHGAP5 mRNA ribosome occupancy mediated by its m6A modification in breast cancer cells transfected with Flag-tagged RPL22 (ribosomal protein L22) upon YTHDF1 silencing [34,35].